Skip to main content
Equibles

Concurrent Investment Advisors, LLC

Position in EVO — Evotec SE

CIK 2001015 Tampa, FL
Back to EVO Full portfolio

Position in EVO

as of Jun 30, 2026 · filed Jul 27, 2026
Position Value
$28,044
+$3,004 QoQ
Shares Held
10,016
0.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#21
of 34 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in EVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Concurrent Investment Advisors, LLC holds $11,325,302 across 18 Drug Manufacturers - Specialty & Generic names. EVO ranks #17 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 34,405 $2,472,342
2 GLAS
Glass House Brands Inc.
 147,253 $1,914,289
3 HIMS
Hims & Hers Health, Inc.
 35,272 $1,222,879
4 AMRX
Amneal Pharmaceuticals, Inc.
 60,025 $1,039,032
5 UTHR
UNITED THERAPEUTICS Corp
 1,852 $1,003,468
6 TRLV
Trulieve Cannabis Corp.
 100,761 $990,480
7 VTRS
Viatris Inc
 45,255 $718,648
8 TEVA
Teva Pharmaceutical Industries Ltd
 11,370 $385,214

All Filings in EVO

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $28,044 10,016
2026-03-31 $25,040 10,016